111 related articles for article (PubMed ID: 6221545)
41. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
[TBL] [Abstract][Full Text] [Related]
42. Rat aortic strip as a bioassay tissue for thromboxane A2 and rabbit aorta contracting substance (RCS) released from guinea pig lung by bradykinin or anaphylaxis.
Hemker DP; Aiken JW
Prostaglandins; 1979 Feb; 17(2):239-48. PubMed ID: 441434
[No Abstract] [Full Text] [Related]
43. Pharmacology of synthetic thromboxane A2.
Bunting S; Buchanan LV; Holzgrefe HH; Fitzpatrick FA
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():192-8. PubMed ID: 2959046
[No Abstract] [Full Text] [Related]
44. Constitutional thrombocytopathy with subnormal response to thromboxane A2.
Samama M; Lecrubier C; Conard J; Hotchen M; Breton-Gorius J; Vargaftig B; Chignard M; Lagarde M; Dechavanne M
Br J Haematol; 1981 Jun; 48(2):293-303. PubMed ID: 7195274
[TBL] [Abstract][Full Text] [Related]
45. Preventive effect of ONO-3708 on thrombosis and vasospasms in vitro and in vivo.
Kondo K; Seo R; Kitagawa T; Omawari N; Kira H; Okegawa T; Kawasaki A
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():423-6. PubMed ID: 2959089
[No Abstract] [Full Text] [Related]
46. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
Dickinson RP; Dack KN; Long CJ; Steele J
J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
[TBL] [Abstract][Full Text] [Related]
48. Antagonism of thromboxane analog-induced vasoconstriction by non-steroidal anti-inflammatory agents.
Smith EF; Schmunk GA; Lefer AM
J Cardiovasc Pharmacol; 1981; 3(4):791-800. PubMed ID: 6167808
[TBL] [Abstract][Full Text] [Related]
49. Developments of TXA2 antagonists.
Hamanaka N
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():663-5. PubMed ID: 2526556
[No Abstract] [Full Text] [Related]
50. [Structure activity relationship of colistin derivatives].
Yokota M
Nihon Yakurigaku Zasshi; 1971 Nov; 67(6):657-70. PubMed ID: 4401054
[No Abstract] [Full Text] [Related]
51. Role of thromboxane A2 in myocardial ischemia and circulatory shock.
Lefer AM
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():321-6. PubMed ID: 2526491
[No Abstract] [Full Text] [Related]
52. Protective effects of a novel thromboxane analog in lethal traumatic shock.
Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL
Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102
[TBL] [Abstract][Full Text] [Related]
53. [Thromboxane antagonists].
Hof-Mussler S
Med Monatsschr Pharm; 1991 Apr; 14(4):98-9. PubMed ID: 2051965
[No Abstract] [Full Text] [Related]
54. [Relationship between the chemical structure and uterine action of aralkylhydrazines and aralkylamines].
Kudrin AN; Koroza GS
Farmakol Toksikol; 1967; 30(6):718-22. PubMed ID: 5598445
[No Abstract] [Full Text] [Related]
55. An observation of thromboxane A2 in arterial blood after cholesterol feeding in rabbits.
Shimamoto T; Kobayashi M; Takahashi T; Takashima Y; Sakamoto M; Morooka S
Jpn Heart J; 1978 Sep; 19(5):748-53. PubMed ID: 731937
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and thromboxane A2 antagonistic activity activity of indane derivatives.
Shinozaki K; Sato H; Iwakuma T; Sato R; Kurimoto T; Yoshida K
Bioorg Med Chem Lett; 1999 Feb; 9(3):401-6. PubMed ID: 10091692
[TBL] [Abstract][Full Text] [Related]
57. Hypotensive prostaglandin structure activity relationships: 11-desoxy-16-aryl-omega-tetranor prostaglandins.
Schaaf TK; Johnson MR; Eggler JF; Bindra JS; Constantine JW; Hess HJ
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():313-8. PubMed ID: 6221542
[No Abstract] [Full Text] [Related]
58. Cardiovascular effects of glyceryldinitrates as compared to glyceryltrinitrate.
Bogaert MG; Rosseel MT; Deschaepdryver AF
Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):458-60. PubMed ID: 4975307
[No Abstract] [Full Text] [Related]
59. [Isolation, determination and characterization of a new vasoactive polypeptide occurring in the vessel wall].
Laszt L
Angiologica; 1967; 4(3-4):147-60. PubMed ID: 4951613
[No Abstract] [Full Text] [Related]
60. The synthesis and biological activity of omega-pentanor-15-alkylcyclobutyl-PGE1 analogs.
Arndt HC; Gardiner PJ; Hong E; Kluender HC; Myers C; Woessner WD
Prostaglandins; 1978 Jul; 16(1):67-77. PubMed ID: 704925
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
